Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 0378-9671

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 0378-9671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL by Mylan Pharmaceuticals Inc. The label includes dosage form as solution for oral inhalation only, identifies the product NDC as 0378-9671-93, and specifies the package contains 30 x 3 mL sterile unit-dose vials. Ingredients and manufacturer information are also visible.*

FDA Label Image

Figure 3.1-1. Chemical Structure Of Albuterol Sulfate (Ipratropium 01)

Chemical structure of Ipratropium Bromide, as indicated by the molecular formula with constituent atoms and sulfuric acid (H2SO4) shown. The diagram depicts the arrangement of chemical groups in the compound.*

FDA Label Image

Figure 3.1-2. Chemical Structure Of Ipratropium Bromide. (Ipratropium 02)

Chemical structure of Ipratropium Bromide showing the molecular arrangement including a quaternary ammonium group and aromatic ring, along with bromide and water components indicated as Br · H2O.*

FDA Label Image

Figure 3.1-3 (Ipratropium 03)

A line graph depicting lung volume in liters over time in hours after dosing. It compares Albuterol, Ipratropium, and their combination, Ipratropium Bromide and Albuterol Sulfate, showing volume changes across an 8-hour period with each treatment's effect represented by different dashed lines and markers.*

FDA Label Image

Figure 1 (Ipratropium 04)

Illustration depicting the preparation of an inhalation solution, showing a vial being filled with liquid from a dropper under a faucet. This image likely demonstrates the steps to prepare or dilute the Ipratropium Bromide and Albuterol Sulfate respiratory solution for inhalation use.*

FDA Label Image

Figure 2 (Ipratropium 05)

An instructional line drawing illustrating a respiratory inhalation setup, showing a hand holding a device with a mouthpiece and a connecting tube, alongside a person inhaling through the mouthpiece.*

FDA Label Image

Figure 3 (Ipratropium 06)

An instructional illustration showing a person using a respiratory inhalation device. The person is depicted placing the mouthpiece in their mouth while holding the device with their hand, demonstrating the correct technique for inhaling a solution.*

FDA Label Image

Figure 4 (Ipratropium 07)

An instructional diagram showing a person using a respiratory inhalation solution with a mouthpiece and spacer device. The illustration demonstrates the proper way to hold and use the inhaler for administering the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.